These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1071632)

  • 1. Influence of spironolactone on endogenous steroid metabolism in man.
    Abshagen U; Spörl S; Schöneshöfer M; L'age M; Rennekamp H; Oelkers W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():307s-310s. PubMed ID: 1071632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of spironolactone on electrolytes, renin, ACTH and corticosteroids in the rat.
    Chabert PR; Guelpa-Decorzant C; Riondel AM; Vallotton MB
    J Steroid Biochem; 1984 Jun; 20(6A):1253-9. PubMed ID: 6087026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
    Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
    Millar JA; Fraser R; Mason P; Leckie B; Cumming AM; Robertson JI
    Br J Clin Pharmacol; 1984 Sep; 18(3):369-75. PubMed ID: 6386025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone escape to chronic ACTH administration in man.
    Gaillard RC; Riondel AM; Favrod-Coune CA; Vallotton MB; Muller AF
    Acta Endocrinol (Copenh); 1983 May; 103(1):116-24. PubMed ID: 6305073
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.
    Favre L; Glasson P; Riondel A; Vallotton MB
    Clin Sci (Lond); 1983 Apr; 64(4):407-15. PubMed ID: 6337769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man.
    Tuck ML; Sowers JR; Fittingoff DB; Fisher JS; Berg GJ; Asp ND; Mayes DM
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1057-61. PubMed ID: 6262360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma aldosterone level in a female case of pseudohyperaldosteronism (Liddle's syndrome).
    Takeuchi K; Abe K; Sato M; Yasujima M; Omata K; Murakami O; Yoshinaga K
    Endocrinol Jpn; 1989 Feb; 36(1):167-73. PubMed ID: 2659310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced variations of the renin-angiotensin-aldosterone system in rats. I. Diuretics.
    Palazzoadriano M; Albano V; Bellanca L; Latteri S; Valdes L
    Pharmacol Res Commun; 1977 Nov; 9(10):939-53. PubMed ID: 605153
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of spironolactone on aldosterone regulation in man.
    Gaillard RC; Riondel AM; Chabert P; Vallotton MB
    Clin Sci (Lond); 1980 Mar; 58(3):227-33. PubMed ID: 6244912
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
    Lammintausta R; Erkkola R
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):294-8. PubMed ID: 489194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aldosterone in the sodium retention of patients with nephrotic syndrome.
    Shapiro MD; Hasbargen J; Hensen J; Schrier RW
    Am J Nephrol; 1990; 10(1):44-8. PubMed ID: 2188506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
    Desmit EM; Cost WS; Brown JJ; Fraser R; Lever AF; Robertson JI
    Acta Endocrinol (Copenh); 1970 May; 64(1):75-94. PubMed ID: 4318377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.